2100 patienter i kliniske undersøgelser i op til 24 ugers varighed med placebo og aktiv kontrol.
It was also evaluated for treatment of the inflammation and pain of RA in approximately 2100 patients in placebo and active controlled trials of up to 24 weeks duration.